journal cover

Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran

Vaccine

Oct 24, 2019

Seyed Mohsen ZahraeiAzam Sabouri

Get paper from

Abstract

Measles and rubella as two highly contagious eruptive diseases are on the agenda to be eliminated in Iran by 2020. To evaluate the seroimmunity of the future mothers against rubella and measles, a nationwide serosurvey was implemented in 10 provinces, selected at random from 31 province...read more

Mentioned in this Paper

Academic Medical Centers
Enzyme-Linked Immunosorbent Assay
Immunization Schedule
Schools, Public Health
Vaccines
Woman
Random Sampling
Blood Specimen
Health Campaigns
Serum
Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran

Vaccine

Oct 24, 2019

Seyed Mohsen ZahraeiAzam Sabouri

PMID: 31668816

DOI: 10.1016/j.vaccine.2019.10.026

Abstract

Measles and rubella as two highly contagious eruptive diseases are on the agenda to be eliminated in Iran by 2020. To evaluate the seroimmunity of the future mothers against rubella and measles, a nationwide serosurvey was implemented in 10 provinces, selected at random from 31 province...read more

Mentioned in this Paper

Academic Medical Centers
Enzyme-Linked Immunosorbent Assay
Immunization Schedule
Schools, Public Health
Vaccines

Related Papers

Paper Details
References
  • References
  • Citations
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Get paper from

/papers/seroprevalence-of-anti-rubella-and-anti-measles/31668816